Lexpert Special Editions

Lexpert Special Edition on Health Sciences

The Lexpert Special Editions profiles selected Lexpert-ranked lawyers whose focus is in Corporate, Infrastructure, Energy and Litigation law and relevant practices. It also includes feature articles on legal aspects of Canadian business issues.

Issue link: https://digital.carswellmedia.com/i/1379015

Contents of this Issue

Navigation

Page 10 of 43

www.lexpert.ca 9 Agarwal, Rahool Lax O'Sullivan Lisus Gottlieb LLP > (416) 645-1787 ragarwal@lolg.ca Rahool's practice focuses on complex commercial and civil litigation, including class actions, contractual disputes, shareholder disputes, proxy fights, director and officer liability, and complex fraud cases. He is frequently called upon to handle time-sen- sitive disputes and has extensive experience bringing and defending urgent court proceedings. Rahool has also acted in a broad range of constitutional and public law matters, including cases involving the constitutionality of a safe injection site, the application of state immunity to claims of torture and the discretion of physicians to unilaterally withdraw life support. Rahool has appeared before all levels of court in Ontario, the Quebec Court of Appeal, the BC Court of Appeal and in six cases in the Supreme Court of Canada. He also regularly appears before the Toronto Commercial List. He is also actively engaged in the broader legal community. Rahool is a member of the editorial board of the Commercial Litigation and Arbitration Review and a member of e Advocates' Society's 10+ Committee, and was previously coach of the Lakehead University Wilson Moot team and a member of the board of directors of the South Asian Legal Clinic (Ontario). Balakrishnan, Desmond McMillan LLP > (604) 691-7462 desmond.balakrishnan@mcmillan.ca Desmond Balakrishnan is a partner in McMillan's Corporate Finance/Securities practice and co-chairperson of both McMil- lan's Cannabis Practice Group and Entertainment and Gaming Law Group. He is one of the most prominent securities lawyers in Vancouver, Canada, having completed billions of dollars in transactions thus far. In addition to his focus on cannabis law, his areas of practice include investments, public offerings, new listings, mergers, acquisitions, listed company maintenance, gaming, entertainment and hospitality law. Desmond has acted as counsel on new issues and listings on all Canadian stock exchanges and inter-listings with several international exchanges — for domestic and foreign entities alike. Desmond's cannabis clients include public and private Canadian and foreign companies as well as financial services providers, such as asset management and investment funds. Desmond is highly sought aer for his cannabis law expertise and has been advising on some of Canada's largest and precedent-setting transactions to date. Desmond also serves on the board of directors of a number of NYSE, TSE and TSXV listed companies. Biron, Caroline Woods LLP > (514) 982-6628 cbiron@woods.qc.ca Managing partner at Woods LLP, Caroline has been practising in the field of commercial and corporate litigation since her admission to the Quebec bar in 1992. She has pleaded before the Supreme Court of Canada, the Superior Court, the Court of Appeal and the Federal Court, as well as several administrative tribunals. She has also participated in numerous arbitrations. As a litigator, she has experience with almost every type of civil claim, across a broad range of industries, including financial services, medical, pharmaceuticals, insurance, investment funds, media, telecommunications, technology, consumer products, real estate, transportation, travel retail, publishing and professional consulting and accounting. Caroline also has significant and varied experience in defending against class action proceedings involving product liability, false advertising, competition law, intellectual property and the manipulation of financial instruments. She has considerable experience in matters of professional liability (including directors' and officers' liability) and litigation involving financial institutions, injunctions, and defamation. Dewan, Rajeev McMillan LLP > (416) 865-7878 raj.dewan@mcmillan.ca Rajeev (Raj) Dewan is a Toronto-based partner in the firm's Capital Markets and M&A groups. Raj brings significant expertise acting on behalf of high-growth companies in the health-care / life sciences, biotech, fintech, technology and eSports sectors. Raj advises on all facets of corporate and securities law, going public transactions, financings and mergers & acquisitions. As a member of McMillan's Hong Kong office, Raj's practice has a particular focus on cross-border transactions and listings in and from emerging markets with North American technology companies. Raj is on the Listing Advisory Committee (Ontario) of the TSXV — advising senior management of the TSX on listing policy regulation and trends; a member of the Singapore Institute of Directors; a charter member of the Toronto Chapter of TiE Global; and a mentor of SuperCharger FinTech Accel- erator (a Hong kong based accelerator), advising Asian fintech companies on all aspects of corporate finance and cross-border partnerships. Dipchand, Elizabeth S. Dipchand LLP > (416) 504-5805 edipchand@dipchand.com Elizabeth's passion and curiosity for life sciences stems far before her legal career. Her undergraduate work (double honours in genetics and biochemistry) laid a strong foundation for her future; her lab work throughout undergrad and even into law school was NSERC funded. Her curiosity continued into her Master of Law research, where she delved deeply into the regula- tion of biologics and biosimilars in the U.S. and E.U. in comparison with Canada culminating in her work entitled "Biosimilars: e Quest for a Rational Regulatory and Intellectual Property Approach in Canada." Serving life sciences clients is a privilege for Elizabeth and her team. Her desire to find intelligent solutions in the hidden paths forward, around or through problems not readily evident to others drives her passion. Early in her career, Elizabeth's practice focused on pharmaceutical patent litigation, including PM(NOC) proceedings and drug and biologics regulatory law. She commonly advises on IP identifica- tion issues, acquisitions through R&D, ventures and partnerships, IP management through lifecycle strategies, licensing and assignments and leveraging the technology for the prosperity of the venture. As well, clients rely on her abilities to protect and enforce the critical rights at the core of their business. Lexpert-ranked leading health sciences lawyers www.lexpert.ca 9

Articles in this issue

Links on this page

Archives of this issue

view archives of Lexpert Special Editions - Lexpert Special Edition on Health Sciences